Clinical and Molecular Hepatology (CMH) 현황 보고
Noticeable articles in CMH Volume 26(4); Oct 2020
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
Yu Rim Lee1, 2, 3, *, Min Kyu Kang3, 4, *, Jeong Eun Song3, 5, Hyun Jung Kim3, 6, Young Oh Kweon1, 2, 3, Won Young Tak1, 2, 3, Se Young Jang1, 2, 3, Jung Gil Park3, 4, Changhyeong Lee3, 5, Jae Seok Hwang3, 6, Byoung Kuk Jang3, 6, Jeong Ill Suh3, 7, Woo Jin Chung3, 6, Byung Seok Kim3, 5, Soo Young Park1, 2, 3
1Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea, 2Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea, 3Daegu-Gyeongbuk Liver Study Group, 4Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea, 5Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea, 6Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea, 7Department of Internal Medicine, Dongguk University Gyeongju Hospital, Dongguk University College of Medicine, Gyeongju, Korea
Liver cirrhosis was more common in COVID-19 patients with severe pneumonia than in those with non-severe pneumonia. Compared to patients without liver cirrhosis, patients with liver cirrhosis had a significantly higher proportion of oxygen therapy, admission to ICU, septic shock, acute respiratory distress syndrome, acute kidney injury, and death. The presence of liver cirrhosis was significantly associated with disease severity and death in COVID-19 patients.
CMH를 인용한 SCIE 논문 조사 현황
올한해 CMH 인용사업에 많은 도움을 주신 회원분들께 감사드리며, 내년에도 CMH 논문들이 활발하게 인용될 수 있도록 많은 관심과 도움을 부탁 드립니다.
|